Related Experiment Video

Updated: Aug 16, 2025

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

13.7K

[Bone pseudoprogression due to renal neoplasia during treatment with immune checkpoint inhibitors]

Darío A Rueda1, Ailén Martiarena1, Carlos Bas1

  • 1Instituto de Oncología, Hospital Alemán, Buenos Aires, Argentina.

Medicina
|December 26, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
10:11

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Published on: January 3, 2013

23.2K
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.8K

Related Experiment Videos

Last Updated: Aug 16, 2025

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

13.7K
Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
10:11

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Published on: January 3, 2013

23.2K
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.8K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K

Articles linked to this work by shared authors, journal, and citation graph.

Treatment Trends in Metastatic Renal Clear Cell Carcinoma in Argentina.

JCO global oncology·2025

[Primary hepatic sarcomatoid carcinoma, an unusual case].

Medicina·2024

Type 1 diabetes and subcutaneous insulin resistance syndrome treated with pancreas transplantation.

Medicina·2021

[Acquired paraneoplastic hemophilia secondary to Vater's ampulla adenocarcinoma].

Medicina·2021

[Febrile agranulocytosis and reactive arthropathy associated with cocaine consumption in an HLA B27 positive patient].

Medicina·2020

Efficacy and Safety of Nivolumab in Previously Treated Patients With Non-Small-cell Lung Cancer: Real World Experience in Argentina.

Clinical lung cancer·2020

[Guide to approaching the first demyelinating event in pediatrics].

Medicina·2026

[Recommendations for the diagnosis and treatment of optic neuromyelitis in children and adolescents].

Medicina·2026

[Disease associated with anti-myelin oligodendrocyte glycoprotein (MOGAD)].

Medicina·2026

[Update guide on pediatric multiple sclerosis].

Medicina·2026

[Guidelines for Serotonin Syndrome in Pediatrics].

Medicina·2026

[Neuroleptic Malignant Syndrome].

Medicina·2026

Application of magnetic hyperthermia in prostate cancer treatment.

Acta of bioengineering and biomechanics·2026

Ultrasonography of the recurrent laryngeal nerve in thyroid cancer: advances in clinical application and research progress.

Frontiers in oncology·2026

Lutetium-177 radiopharmaceuticals in cancer care: progress and challenges.

Frontiers in pharmacology·2026

Rectovaginal fistulas after radiation therapy: treatment options and outcomes - a narrative review.

Frontiers in oncology·2026

Radiation resistance is a property of long-lived plasma cells but not their precursors.

Immunotherapy advances·2026

Repeated romosozumab with short-term ibandronate sequencing in high-risk osteoporosis: a retrospective single-center cohort study.

JBMR plus·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us